CHIMERA INVESTMENT CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CHIMERA INVESTMENT CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
General and administrative	17.5	17.7	22.7	23.9	22.9	22.2	22.7	25.1	23.2	30
Interest expense	348	533	679	759	516	327	333	510
Interest income	934	1,139	1,273	1,361	1,030	938	773	773
Pre-tax income	552	525	412	414	89	675	-513	126	176	233
Income tax	0.08	0.11	0.09	0.19	0.16	4.41	-0.25	0.1	0.05	2.27
Net income	552	525	412	414	88.9	670	-513	126	176	230
EPS, basic	8.79	7.86	5.91	5.46	0.21	7.65	-7.53	0.68	1.12	1.76
EPS, diluted	8.76	7.83	5.88	5.43	0.21	7.32	-7.53	0.68	1.10	1.72
Shares, basic (weighted)	62.6	62.6	62.4	62.4	71	77.9	78	76.7	81	82.2
Shares, diluted (weighted)	62.7	62.8	62.6	62.8	75.5	81.8	78	77.5	82.2	83.9
Dividend per share	7.32	6.00	6.00	6.00	4.20	3.87	1.12	2.10	1.42	1.48

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	178	63.6	47.5	110	269	386	265	222	84	279
Total assets	16,685	21,222	27,709	27,119	17,523	15,407	13,402	12,929	13,116	15,809
Total liabilities	13,561	17,587	24,005	23,165	13,744	11,671	10,735	10,370	10,590	13,236
Total debt				0	51.6	0		0	135	252
Paid-in capital	3,509	3,827	4,072	4,276	4,538	4,359	4,318	4,370	4,391	4,429
Retained earnings	2,443	2,968	3,379	3,793	3,882	4,552	4,039	4,165	4,341	4,572
Other comprehensive income	718	797	627	708	558	405	229	186	159	146
Shareholders' equity	3,124	3,635	3,704	3,953	3,779	3,736	2,667	2,559	2,526	2,573
Total equity	3,124	3,635	3,704	3,953	3,779	3,736	2,667	2,559	2,526	2,573
Total liabilities and equity	16,685	21,222	27,709	27,119	17,523	15,407	13,402	12,929	13,116	15,809
Shares outstanding	62.6	62.6	62.4	62.4	76.9	79	232	80.5	80.9	83.4

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	552	525	412	414	88.9	670	-513	126	176	230
Stock-based compensation	2	4	8.8	10.6	5.02	6.51	8.18	9.55	10.1	9.69
Deferred income tax									0	-0.15
Cash from operations	553	487	298	65	258	519	326	213	206	-249
Acquisitions							0	0	-29.1
Cash from investing	-1,271	-4,331	-6,026	1,237	8,330	2,548	510	552	178	-1,657
Stock issued	0					0	0	73.8	0	0
Share buybacks	0	0	-14.8	0	-22.1	-1.83	-48.9	-33.1	0	0
Dividends paid	-454	-376	-374	-374	-323	-299	-288	-195	-119	-123
Cash from financing	781	3,730	5,712	-1,240	-8,429	-2,951	-957	-808	-522	2,106
Net change in cash	63.7	-114	-16.1	62.4	159	117	-121	-42.9	-138	200
Interest paid	335	512	644	835	578	339	323	470	479	535
Income taxes paid				0.19	0.16	4.41	-0.25	0.1	0.05	3.53

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $25.08 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Return on equity (ROE)	0.1%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	0.0%	Net income / average total assets.

Growth

Metric	Value	How it is calculated
Net income growth, 1y	30.9%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 5y	21.0%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	56.4%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 5y	52.3%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-221.0%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Dividend per share growth, 1y	4.2%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	9.7%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	-18.8%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	1.8%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-1.2%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-7.4%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	20.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	5.7%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-2.0%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	2.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	2.5%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	2.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Debt / equity	0.10x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	1.6%	Total debt / total assets.
Liabilities / assets	84.9%	Total liabilities / total assets.
Net debt	-$191.5M	Total debt - cash - short-term investments. Negative means more cash than debt.
Tangible book value	$2.42B	Shareholders' equity - goodwill - intangible assets.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$1.02	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Operating cash flow per share	-$4.61	Cash from operations / diluted weighted shares.
Book value per share	$28.86	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$28.86	Tangible book value / shares outstanding.
Cash per share	$5.30	(Cash + short-term investments) / shares outstanding.
Payout ratio	10,894.0%	Dividends paid / net income, when net income is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$2.02B	Share price x shares outstanding.
Enterprise value	$1.83B	Market cap + total debt - cash - short-term investments.
P/E	1,668x	Market cap / net income. Only when net income is positive.
P/B	0.84x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.84x	Market cap / tangible book value, when positive.
Earnings yield	0.1%	Net income / market cap (the inverse of P/E).
Dividend yield	6.5%	Dividends paid over the period / market cap.
Shareholder yield	6.5%	(Dividends paid + share buybacks) / market cap.

Was CHIMERA INVESTMENT CORP profitable in fiscal 2025?

Yes. Net income was $230.5M, a net margin of -.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to CHIMERA INVESTMENT CORP